Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease Activity.

Chen, Dhruti P; McInnis, Elizabeth A; Wu, Eveline Y; Stember, Katherine G; Hogan, Susan L; Hu, Yichun; Henderson, Candace D; Blazek, Lauren N et al. · J Am Soc Nephrol · 2022

prospective_cohort · Level II

Where this comes from

Abstract

PR3-ANCA vasculitis has a genetic association with HLA-DPB1. We explored immunologic and clinical features related to the interaction of HLA-DPB1*04:01 with a strongly binding PR3 peptide epitope (PR3<sub>225-239</sub>). Patients with ANCA vasculitis with active disease and disease in remission were followed longitudinally. Peripheral blood mononuclear cells from patients and healthy controls with HLA-DPB1*04:01 were tested for HLA-DPB1*04:01 expression and interaction with a PR3 peptide identified <i>via in silico</i> and <i>in vitro</i> assays. Tetramers (HLA/peptide multimers) identified autoreactive T cells <i>in vitro.</i> RESULTS: The HLA-DPB1*04:01 genotype was associated with risk of relapse in PR3-ANCA (HR for relapse 2.06; 95% CI, 1.01 to 4.20) but not in myeloperoxidase (MPO)-ANCA or the combined cohort. <i>In silico</i> predictions of HLA and PR3 peptide interactions demonstrated strong affinity between ATRLFPDFFTRVALY (PR3<sub>225-239</sub>) and HLA-DPB1*04:01 that was confirmed by <i>in vitro</i> competitive binding studies. The interaction was tested in <i>ex vivo</i> flow cytometry studies of labeled peptide and HLA-DPB1*04:01-expressing cells. We demonstrated PR3<sub>225-239</sub> specific autoreactive T cells using synthetic HLA multimers (tetramers). Patients in long-term remission off therapy had autoantigenic peptide and HLA interaction comparable to that of healthy volunteers. The risk allele HLA-DPB1*04:01 has been associated with PR3-ANCA, but its immunopathologic role was unclear. These studies demonstrate that HLA-DPB1*04:01 and PR3<sub>225-239</sub> initiate an immune response. Autoreactive T cells specifically recognized PR3<sub>225-239</sub> presented by HLA-DPB1*04:01. Although larger studies should validate these findings, the pathobiology may explain the observed increased risk of relapse in our cohort. Moreover, lack of HLA and autoantigen interaction observed during long-term remission signals immunologic nonresponsiveness.

Medical subject headings